We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Developing Therapeutics To Combat ALS

In this interview, we speak to Alon Ben-Noon, CEO and co-founder of Neurosense Therapeutics to hear about the impact their drug development strategy is having on the ALS field.
Industry Insight

Exploring the Ethical Challenges of Brain-Computer Interface Technology

This article explores the current state of brain-computer interface technology and some of the ethical considerations associated with its use.
Industry Insight

Research Collaboration Yields New Treatment Possibilities for ALS

Frank Pun discusses how scientists from Insilico Medicine identified numerous unreported potential therapeutic targets of amyotrophic lateral sclerosis using the company’s proprietary AI-enabled biological target discovery platform.
Industry Insight

Alzheimer’s Breakthrough: A Disruptive Systemic Approach Is Poised To Demonstrate Value

Today’s treatments for AD are limited and unsatisfactory. This article explores a drug development effort that is taking a completely different approach – not trying to cure the disease but actually repair the damage.
Industry Insight

Harnessing AI as a Wellness Tool for Teenagers’ Mental Health

To learn more about Kai – an AI-powered personal guide and companion – and the potential benefits of using AI as a wellness tool for mental health, Technology Networks spoke to Alex Frenkel.
Industry Insight

Extending the Reach of Psychedelic Therapy With Psychoplastogens

Delix Therapeutics is developing non-hallucinogenic psychedelics for use as at-home medications for mental health conditions. To find out more, we spoke to the CEO, Mark Rus.
Industry Insight

What’s the Best Way To Take 5-MeO-DMT in a Clinical Trial?

Beckley Psytech recently announced that they have dosed the first healthy volunteers in their Phase I trial of an intranasally delivered formulation of 5-MeO-DMT, named BPL-003. To find out more about their trial approach and wider research into 5-MeO-DMT, we spoke to Beckley’s chief scientific offer, Dr. Steve Wooding.
Industry Insight

The Software Advances Powering the Next Generation of Brain Implants

Blackrock Neurotech, a leader in brain-computer interface (BCI) device design, recently has announced a collaboration with Venice, CA-based software developer AE Studio. To find out more, we spoke to Evan Coopersmith, AE Studio’s executive vice-president of data science.
Industry Insight

The Impact of Funding on Longevity Research

To find out more about how early-stage funding could improve longevity research, we had the pleasure of speaking to Garri Zmudze, executive director of the Longevity Science Foundation.
Industry Insight

How Researchers Are Bringing Sustainability to Scientific Discovery

Research is advancing exciting areas of science at an unprecedented pace, but the disposable materials, powered equipment and shipping associated with experiments, sample storage and transport of reagents contribute to high energy consumption and significant waste. How are researchers bringing sustainability to scientific discovery?
Advertisement